Please provide your email address to receive an email when new articles are posted on . Researchers analyzed data from 1,094 individuals with relapsing MS. At 2 years, treatment with ublituzimab ...
A recent study by Baycrest reveals that an area of the brain distinct from the stroke lesion may play a significant role in causing the life-altering symptoms survivors are often left with, which can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results